Search hospitals > Ohio > Dayton
Kettering Medical Center
Claim this profileDayton, Ohio 45429
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Cervical Adenocarcinoma
512 reported clinical trials
8 medical researchers
Summary
Kettering Medical Center is a medical facility located in Dayton, Ohio. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Cervical Adenocarcinoma and other specialties. Kettering Medical Center is involved with conducting 512 clinical trials across 550 conditions. There are 8 research doctors associated with this hospital, such as Howard M. Gross, Thomas Reid, MD, Mark Hoeprich, MD, and Brian Schwartz, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Howard M. GrossKettering Medical Center6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Breast Cancer
134 reported clinical trials
199 drugs studied
Thomas Reid, MDMemorial Hospital of South Bend2 years of reported clinical research
Studies Ovarian Cancer
Studies Parotid Gland Cancer
23 reported clinical trials
49 drugs studied
Mark Hoeprich, MDKettering Health2 years of reported clinical research
Studies Glioblastoma
Studies Cancer
4 reported clinical trials
10 drugs studied
Brian Schwartz, MDKettering Medical Center3 years of reported clinical research
Studies Congenital Aortic Stenosis
Studies Aortic Stenosis
4 reported clinical trials
6 drugs studied
Clinical Trials running at Kettering Medical Center
Breast Cancer
Lung Cancer
Cancer
Bladder Cancer
Breast cancer
Parotid Gland Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Kidney Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kettering Medical Center?
Where is Kettering Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Kettering Medical Center accept?
What awards or recognition has Kettering Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.